It was our third most popular article in 2018, and it’s not hard to understand why: “One drug could treat Alzheimer, MS, Crohn’s disease and more” captured the attention of readers around the world.
“I received quite a high number of mails, mostly from patients or relatives of patients, for instance families of Alzheimer’s patients,” says Prof. David Naor of the Lautenberg Center for Immunology and Cancer Research at the Hebrew University of Jerusalem’s Faculty of Medicine.
